ImmunoSigns CSO, Carl-Henrik Brogren, lecturing on Lab-on-a-Chip technologies and microfluidic analytical methods for Confex, Denmark on June 7, 2007.
ImmunoSigns CSO, Carl-Henrik Brogren, lecturing on Lab-on-a-Chip technologies and microfluidic analytical methods for Confex, Denmark on June 7, 2007.
ImmunoSigns is a Biotech company founded in 1996. We offer you help in project management and R&D activities within biotechnology and immunodetection.
The core competance of ImmunoSigns is development and production of polyclonal and monoclonal antibodies and design and production of novel immunoassays and diagnostic kits, especially within the clinical area of diabetes and obesity.